Study of Two Dose Levels of RTA 402 in Patients With Advanced Malignant Melanoma
Clinical trial NCT00535314 · WITHDRAWN
Trial details
- NCT number
- NCT00535314
- Sponsor
- Biogen
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.